[{"indications": "Indications\u00a0prevention of deep-vein thrombosis\r\nin general or orthopaedic surgery; thromboembolic disease in patients\r\nwith history of heparin-induced thrombocytopenia", "name": "DANAPAROID SODIUM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.8 Anticoagulants and protamine", "2.8.1 Parenteral anticoagulants", "Heparinoids"], "cautions": "Cautions\u00a0recent bleeding or risk of bleeding; concomitant use of drugs\r\nthat increase risk of bleeding;  antibodies\r\nto heparins (risk of antibody-induced thrombocytopenia); body-weight over 90\u00a0kg (monitor anti factor Xa activity)", "side-effects": "Side-effects\u00a0bleeding; hypersensitivity reactions (including\r\nrash)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129019.htm", "doses": ["Prevention of deep-vein thrombosis, by subcutaneous\r\ninjection, 750\u00a0units twice daily for 7\u201310 days; initiate treatment\r\nbefore operation (with last pre-operative dose 1\u20134 hours before surgery)", "Thromboembolic disease in patients with history of heparin-induced\r\nthrombocytopenia, by intravenous injection, 2500\u00a0units\r\n(1250\u00a0units if body-weight under 55\u00a0kg, 3750\u00a0units if over 90\u00a0kg),\r\nfollowed by intravenous infusion of 400\u00a0units/hour\r\nfor 2 hours, then 300\u00a0units/hour for 2 hours, then 200\u00a0units/hour for 5 days"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid\u2014limited information available\r\nbut not known to be harmful"}]